Tango Therapeutics, Inc. has grown revenue 21% a year over three years and 52% a year over five. Revenue growth, 3-year annual rate: +21% (Biotechnology median +21%). Revenue growth, 5-year rate: +52%, growth has slowed since the five-year average. Years of annual history on file: 6, FY2020 to FY2025, as filed.

TNGXTango Therapeutics, Inc.

HealthcareUSD

$25.49

$6.3652 weeks$32.90

Is it growing?

Is TNGX growing?

Tango Therapeutics, Inc. has grown revenue 21% a year over three years and 52% a year over five.

+21%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate: +52%
Revenue growth, 5-year rate · +21% over three · growth has slowed since the five-year average
Years of annual history on file: 6
Years of annual history on file · FY2020 to FY2025, as filed

Details›